Apposite Capital

Apposite Capital is a prominent London-based private equity firm with a dedicated focus on healthcare services and life sciences companies across the UK, Europe, and North America. Established with a clear mandate, the firm specializes in growth equity and buyout investments, targeting businesses poised for significant expansion and value creation within the dynamic healthcare sector. Their strategic approach is rooted in identifying companies with strong fundamentals and providing both capital and operational expertise to accelerate their growth trajectories.

The firm's investment strategy typically involves taking significant minority or control stakes in companies with enterprise values ranging from approximately £20 million to £200 million. Apposite Capital seeks to partner with experienced management teams, leveraging its deep sector knowledge and extensive network to drive strategic initiatives, operational improvements, and market expansion. They are known for their hands-on approach, working closely with portfolio companies to navigate regulatory landscapes, optimize business models, and execute buy-and-build strategies.

Apposite Capital has a strong track record of successful fundraisings and exits, demonstrating consistent performance in a specialized market. Their most recent fund, Apposite Capital IV, successfully closed in 2023, raising £250 million (approximately $315 million USD), underscoring investor confidence in their sector-specific expertise and investment thesis. Prior to this, Apposite Capital III closed at £185 million in 2019. The firm typically deploys equity cheques ranging from £10 million to £50 million (approximately $12.5 million to $62.5 million USD) per transaction, enabling them to support a diverse range of growth and buyout opportunities within their target sectors. This consistent capital deployment and strategic focus have cemented their reputation as a key player in European healthcare private equity.